High materiality8/10
Mirum Pharmaceuticals price target raised to $152 from $137 at Morgan Stanley
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises Mirum Pharmaceuticals target to $152 from $137; current price $86.06.
- Target raised to $152; current price $86.06.
Key facts
- 01
Target: $152
- 02
Posted price: $86.06
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.